XML 18 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows From Operating Activities:    
Net income (loss) $ (597,225) $ (408,258)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization expense 452,659 430,050
Amortization of debt discount 42,240 46,828
Accretion of asset retirement obligation 3,074 2,895
Common stock payable for directors fees 87,500 87,500
Foreign exchange loss (gain) (12,752) 51,642
Other non cash items (656) (677)
Change in:    
Accounts receivable, net (98,712) 10,835
Inventories 202,013 49,196
Other current assets 4,697 (7,647)
Other assets (11,935) (83,437)
Accounts payable 91,299 67,164
Accrued payroll, taxes and interest 26,420 (40,362)
Deferred revenue (27,649) 0
Other accrued liabilities 36,834 31,691
Payables to related parties 10 2,234
Net cash provided (used) by operating activities 197,817 239,654
Cash Flows From Investing Activities:    
Purchase of properties, plants and equipment (174,388) (151,244)
Net cash used by investing activities (174,388) (151,244)
Cash Flows From Financing Activities:    
Change in checks issued and payable 82,330 (12,776)
Net proceeds from factor (5,440) 20,471
Advance from related party 75,000 0
Payment on advances from related party (75,000) 0
Proceeds from note payable to bank 0 24,827
Principal payments on notes payable to bank (1,556) 0
Principal payments on long-term debt (110,872) (106,439)
Net cash provided (used) by financing activities (35,538) (73,917)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (12,109) 14,493
Cash and cash equivalents at beginning of period 91,332 73,331
Cash and cash equivalents at end of period 79,223 87,824
Noncash investing and financing activities:    
Common stock payable issued to directors $ 175,000 $ 168,750